Current standard values of health utility scores for evaluating cost-effectiveness in liver disease: A meta-analysis

Table 3 EuroQol 5-dimensions 5-levels

Ref.	Total	Mean	SD
Normal healthy individuals
Ratcliffe et al[17]	3386	0.85	0.03
Chong et al[18]	1518	0.821	0.011
Björnsson et al[22]	29353	0.819	0.217
Vahidnia et al[26]	1565	0.94	0.1
Cortesi et al[30]	6800	0.915	0.107
Total	42622	0.8413	0.1905
Compensated cirrhosis with hepatitis C
Chong et al[18]	24	0.74	0.085
Grieve et al[19]	40	0.55	0.34
Björnsson et al[22]	76	0.749	0.212
Scalone et al[25]	222	0.736	0.259
Kaishima et al[27]	20	0.824	0.106
Cortesi et al[30]	574	0.891	0.119
Zanone et al[32]	94	0.68	0.37
Total	1050	0.8113	0.2261
Decompensated cirrhosis with hepatitis C
Chong et al[18]	9	0.66	0.2
Grieve et al[19]	64	0.45	0.24
Björnsson et al[22]	53	0.565	0.266
Kaishima et al[27]	4	0.524	0.25
Cortesi et al[30]	523	0.859	0.14
Total	653	0.7903	0.2182
Sustained virologic response
Chong et al[18]	36	0.83	0.065
Grieve et al[19]	24	0.82	0.21
Björnsson et al[22]	52	0.792	0.209
Zanone et al[32]	91	0.89	0.18
Total	203	0.846	0.1816
Hepatocellular carcinoma
Chong et al[18]	15	0.65	0.21
Grieve et al[19]	64	0.45	0.24
Scalone et al[25]	85	0.777	0.241
Kaishima et al[27]	14	0.75	0.057
Cortesi et al[30]	545	0.867	0.146
Total	723	0.8127	0.2084